Werner Kroll's most recent trade in QuidelOrtho Corporation was a trade of 1,170 Restricted Stock Units done . Disclosure was reported to the exchange on July 28, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Jul 2024 | 1,170 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Jul 2024 | 1,170 | 36,951 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Jul 2024 | 594 | 36,357 (0%) | 0% | 38.9 | 23,113 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Mar 2024 | 3,811 | 37,582 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Mar 2024 | 3,811 | 7,622 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Mar 2024 | 1,801 | 35,781 (0%) | 0% | 47.9 | 86,340 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 08 Feb 2024 | 14,920 | 14,920 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 01 Feb 2024 | 1,313 | 34,451 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 01 Feb 2024 | 1,313 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Kroll Werner | SVP, Research & Development | 01 Feb 2024 | 680 | 33,771 (0%) | 0% | 69.5 | 47,226 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 31 Jan 2024 | 3,628 | 3,628 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 31 Jan 2024 | 3,628 | 33,343 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 31 Jan 2024 | 3,547 | 34,944 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Kroll Werner | SVP, Research & Development | 31 Jan 2024 | 3,547 | 3,548 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Kroll Werner | SVP, Research & Development | 31 Jan 2024 | 1,946 | 31,397 (0%) | 0% | 68.5 | 133,320 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 31 Jan 2024 | 1,806 | 33,138 (0%) | 0% | 68.5 | 123,729 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Jul 2023 | 1,170 | 1,170 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Jul 2023 | 1,170 | 30,188 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Jul 2023 | 549 | 29,639 (0%) | 0% | 87.1 | 47,829 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 01 Jul 2023 | 981 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 01 Jul 2023 | 981 | 29,236 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 01 Jul 2023 | 436 | 28,800 (0%) | 0% | 82.9 | 36,127 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Mar 2023 | 11,433 | 11,433 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 11 Feb 2023 | 2,743 | 0 | - | - | Restricted Stock Units (Converted) | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 11 Feb 2023 | 2,743 | 29,137 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 11 Feb 2023 | 1,296 | 27,841 (0%) | 0% | 86.5 | 112,104 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 11 Feb 2023 | 823 | 0 | - | - | Restricted Stock Units (Premium) | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 11 Feb 2023 | 823 | 28,664 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 11 Feb 2023 | 409 | 28,255 (0%) | 0% | 86.5 | 35,379 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 04 Feb 2023 | 4,268 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 04 Feb 2023 | 4,268 | 28,511 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 04 Feb 2023 | 3,925 | 26,190 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 04 Feb 2023 | 3,925 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 04 Feb 2023 | 2,117 | 26,394 (0%) | 0% | 89.7 | 189,895 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 04 Feb 2023 | 1,947 | 24,243 (0%) | 0% | 89.7 | 174,646 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 31 Jan 2023 | 3,547 | 7,095 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 31 Jan 2023 | 3,547 | 23,393 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 31 Jan 2023 | 1,840 | 21,553 (0%) | 0% | 85.6 | 157,522 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 31 Jan 2023 | 1,312 | 1,313 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 31 Jan 2023 | 1,312 | 22,916 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 31 Jan 2023 | 651 | 22,265 (0%) | 0% | 88.5 | 57,620 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Jul 2022 | 1,170 | 20,427 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Jul 2022 | 1,170 | 2,340 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 28 Jul 2022 | 581 | 19,846 (0%) | 0% | 102.4 | 59,477 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 01 Jul 2022 | 981 | 19,743 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 01 Jul 2022 | 981 | 981 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, Research & Development | 01 Jul 2022 | 486 | 19,257 (0%) | 0% | 97.1 | 47,195 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 18,762 | 0 (0%) | 0% | - | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 18,762 | 18,762 (0%) | 0% | - | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 10,642 | 10,642 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 10,642 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 7,256 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 7,256 | 7,256 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 4,376 | 20,932 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 4,376 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 4,268 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 4,268 | 4,268 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 3,925 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 3,925 | 3,925 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 3,924 | 0 | - | - | Non-Qualified Stock Options | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 3,924 | 3,924 | - | - | Non-Qualified Stock Options | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 3,510 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 3,510 | 3,510 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 2,743 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 2,743 | 2,743 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 2,625 | 2,625 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 2,625 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 2,303 | 0 | - | - | Non-Qualified Stock Options | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 2,303 | 2,303 | - | - | Non-Qualified Stock Options | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 2,170 | 18,762 (0%) | 0% | 103.5 | 224,487 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 1,962 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 1,962 | 1,962 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2022 | 823 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | See Remarks | 27 May 2022 | 823 | 823 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 10 Feb 2022 | 1,050 | 0 | - | - | Restricted Stock Units (Converted) | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 10 Feb 2022 | 1,050 | 16,947 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 10 Feb 2022 | 496 | 16,451 (0%) | 0% | 95.3 | 47,289 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 10 Feb 2022 | 210 | 16,661 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 10 Feb 2022 | 210 | 0 | - | - | Restricted Stock Units (Premium) | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 10 Feb 2022 | 105 | 16,556 (0%) | 0% | 95.3 | 10,011 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 04 Feb 2022 | 4,268 | 4,268 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 04 Feb 2022 | 4,268 | 17,863 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 04 Feb 2022 | 1,966 | 15,897 (0%) | 0% | 98.9 | 194,378 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 31 Jan 2022 | 10,642 | 10,642 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 31 Jan 2022 | 7,256 | 7,256 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 31 Jan 2022 | 1,312 | 14,246 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 31 Jan 2022 | 1,312 | 2,625 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 31 Jan 2022 | 651 | 13,595 (0%) | 0% | 102.3 | 66,610 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 16 Jan 2022 | 4,606 | 0 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 16 Jan 2022 | 4,606 | 15,366 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 16 Jan 2022 | 2,432 | 12,934 (0%) | 0% | 114.9 | 279,388 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 01 Jul 2021 | 982 | 11,229 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 01 Jul 2021 | 982 | 982 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 01 Jul 2021 | 506 | 10,723 (0%) | 0% | 128.6 | 65,072 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2021 | 4,376 | 4,376 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2021 | 4,376 | 12,495 (0%) | 0% | 0 | Common Stock | ||
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 27 May 2021 | 2,248 | 10,247 (0%) | 0% | 121.5 | 273,132 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 22 Feb 2021 | 12,784 | 18,237 (0%) | 0% | 164.1 | 2,097,955 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 22 Feb 2021 | 5,283 | 8,119 (0%) | 0% | 173.7 | 917,734 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 22 Feb 2021 | 4,662 | 13,575 (0%) | 0% | 166.4 | 775,584 | Common Stock | |
| QuidelOrtho Corporation | Werner Kroll | SVP, R&D | 22 Feb 2021 | 3,926 | 31,021 (0%) | 0% | 59.1 | 232,105 | Common Stock |